AZL closes in on Prairie lithium production
Arizona Lithium has submitted the project application for its Prairie lithium project after securing the key water rights licence and other approvals.
Arizona Lithium has submitted the project application for its Prairie lithium project after securing the key water rights licence and other approvals.
Broking analysts have raised their valuation of Telix Pharmaceuticals shares after the company’s bullish update.
Dr Camile Farah joins Fraser Palamara on Stockhead TV
EBR Systems joins Fraser Palamara on Stockhead TV to talk about its final stages of FDA approval.
Pilot Energy’s Korean Consortium partner secures feasibility financing for the Mid West Clean Energy Project in WA.
Pure Hydrogen’s proposed spin-off Eastern Gas will focus on developing its Windorah gas project and Project Venus coal seam gas play in Queensland.
Falling critical minerals prices have hit 50 of Australia’s largest miners, delivering a 37 per cent collective hit to their earnings in 2024.
The Aussie ETF industry has reached $233 billion with international stocks leading inflows, while Betashares launched an ethical Aussie bond ETF.
Chinese car maker BYD appears set to overtake US giant Ford in annual EV shipments. That’s largely because of demand for hybrids – which are also booming in Australia.
Medtech EBR has reported a milestone quarter, highlighted by the final submission of its PMA application for the WiSE CRT system to the FDA.
WA-based gas stocks have every reason to cheer Asian demand growth – and a recent state government decision. Meanwhile, others are getting busy in SA and Queensland.
Collette Capital’s Steve Collette says interest is returning in semiconductor stock Archer Materials, which is eyeing new resistance levels after a mid-year slump.
GTI Energy is on track to update its Lo Herma uranium resource and exploration target by the end of 2024 and is moving to expand its footprint.
Imricor Medical Systems is racing through regulatory initiatives supporting new device approvals in the US and Europe with the US Food and Drug Administration (FDA) completing a review of its first premarket approval (PME) module ahead of schedule.
Original URL: https://www.adelaidenow.com.au/business/stockhead/page/200